# Vitamin C Immunity Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/vitamin-c-immunity-meta-analysis-evidence-review
Category: evidence-review
Summary: Vitamin C Immunity Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed 
Last reviewed: 2026-05-26
Reviewed by: Migaku Evidence Review
# Vitamin C Immunity Meta-analysis: What the Evidence Says

## Quick Answer

Vitamin C Immunity Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Vitamin D and Health Outcomes: State-of-the-Art Review of Triangulated Evidence and Ongoing Controversies | narrative review | 3 | 2026-03-18 | 10.1007/s13668-026-00748-2 |
| Nutrition as a Modifiable Factor in Optimizing Respiratory Health: Evidence from Pulmonary Function Tests | preclinical study | 4 | 2026-04-14 | 10.3390/children13040543 |

## What The Sources Report

- Observational studies have consistently reported associations between low serum 25(OH)D concentrations and increased risks of cardiovascular disease (CVD), diabetes, cancer, autoimmune disorders, respiratory infections, adverse pregnancy outcomes, and all-cause mortality. [Dalamaga Maria (2026); evidence level 3]
- High-risk groups include older adults, individuals with obesity, darker skin pigmentation, limited sun exposure, and those with chronic kidney or liver disease or malabsorptive disorders. [Dalamaga Maria (2026); evidence level 3]
- The diagnosis is supported by a history of recurrent suggestive symptoms correlated with evidence of BHR. [Chereches-Panta Paraschiva (2026); evidence level 4]
- The correlation between FEV1 and MMEF and the level of asthma control or the risk of exacerbation is a topic of ongoing interest. [Chereches-Panta Paraschiva (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For vitamin c immunity meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Dalamaga Maria (2026). Vitamin D and Health Outcomes: State-of-the-Art Review of Triangulated Evidence and Ongoing Controversies. DOI: 10.1007/s13668-026-00748-2. PMCID: PMC12999768. PMID: 41849024. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12999768/
- Chereches-Panta Paraschiva (2026). Nutrition as a Modifiable Factor in Optimizing Respiratory Health: Evidence from Pulmonary Function Tests. DOI: 10.3390/children13040543. PMCID: PMC13114907. PMID: 42073121. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13114907/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.